Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
617.05B | 504.92B | 460.83B | 411.87B | 320.32B | 323.25B | Gross Profit |
228.11B | 182.52B | 155.05B | 134.37B | 88.01B | 76.57B | EBIT |
131.09B | 94.16B | 76.45B | 61.27B | 24.49B | 12.56B | EBITDA |
142.78B | 105.19B | 87.53B | 66.58B | 30.80B | 18.00B | Net Income Common Stockholders |
95.50B | 70.58B | 57.49B | 45.48B | 15.16B | 5.01B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
53.59B | 197.28B | 175.58B | 133.09B | 62.73B | 37.77B | Total Assets |
259.69B | 676.81B | 562.82B | 459.31B | 382.63B | 347.96B | Total Debt |
71.70B | 7.19B | 29.07B | 45.65B | 43.88B | 67.30B | Net Debt |
18.11B | -160.09B | -146.51B | -87.44B | -18.85B | 29.53B | Total Liabilities |
180.59B | 304.90B | 262.89B | 211.52B | 174.09B | 173.82B | Stockholders Equity |
78.65B | 371.87B | 299.89B | 247.71B | 208.38B | 173.94B |
Cash Flow | Free Cash Flow | ||||
-18.54B | 55.92B | 53.11B | 71.60B | 50.49B | 1.42B | Operating Cash Flow |
13.35B | 96.25B | 73.91B | 81.75B | 57.20B | 11.81B | Investing Cash Flow |
-37.57B | -43.46B | -12.51B | -9.95B | -6.24B | -11.29B | Financing Cash Flow |
-35.47B | -35.14B | -20.96B | -4.95B | -27.07B | 4.93B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
$7.29B | 11.27 | 24.78% | 2.69% | ― | ― | ||
62 Neutral | $11.81B | 10.34 | -7.44% | 2.91% | 7.41% | -7.93% | |
$40.40B | 38.56 | 34.01% | 0.47% | ― | ― | ||
$24.08B | 29.85 | 27.22% | 1.22% | ― | ― | ||
$9.06B | 19.86 | 44.53% | 1.74% | ― | ― | ||
$23.50B | 21.72 | 7.22% | 1.40% | ― | ― | ||
77 Outperform | ¥725.30B | 19.70 | 1.21% | 32.13% | 60.02% |